(Q37840389)
Statements
1 reference
Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer. (English)
1 reference
David M O'Malley
1 reference
Patrick S Rheaume
1 reference
Ritu Salani
1 reference
Eric L Eisenhauer
1 reference
Georgia A McCann
1 reference
Jeffrey M Fowler
1 reference
Larry J Copeland
1 reference
18 February 2011
1 reference
1 reference
121
1 reference
2
1 reference
269-272
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference